Sponsor Pipeline

zhoujing Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07018063 Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset… Gastric (Cardia, Body) Cancer Not Yet Recruiting
Get alerts when zhoujing's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free